Advertisement

Lung Cancer

  • 90th anniversary sessions to reflect on past, present, and future of field

    90th anniversary sessions to reflect on past, present, and future of field

    Nichole T. Tanner, MD, MSCR, FCCP, and five other CHEST experts will chair special sessions about 90 years of progress in mechanical ventilation, TB, lung cancer, diffuse lung disease, respiratory vaccines, and asthma.


  • Discussion to examine sublobar resection for early-stage lung cancer

    Discussion to examine sublobar resection for early-stage lung cancer

    Muhammad S. Ali, MD, MS, FCCP, will chair a Monday afternoon panel session on strategies for early-stage lung cancer in the age of sublobar resection.


  • New data confirms ILD as lung cancer risk factor

    New data confirms ILD as lung cancer risk factor

    Bradford C. Bemiss, MD, and Claudia Henschke, PhD, MD, said the study clearly shows patients with interstitial lung disease have an increased risk of lung cancer.


  • Understanding high-risk factors like PM2.5 in lung cancer

    Understanding high-risk factors like PM2.5 in lung cancer

    Renelle Myers, MD, FRCPC, discusses factors beyond tobacco use that clinicians should consider when screening for lung cancer, such as pollution exposure.


  • Updates in ninth edition of TNM classification criteria allow for more precise lung cancer staging

    Updates in ninth edition of TNM classification criteria allow for more precise lung cancer staging

    Hisao Asamura, MD, said the changes are critical to clinical decision-making in the evolving thoracic oncology treatment landscape.


  • Exploring the evolving landscape in combination therapies for EGFR-mutated advanced NSCLC

    Exploring the evolving landscape in combination therapies for EGFR-mutated advanced NSCLC

    Susan Scott, MD, discussed the findings from the MARIPOSA and FLAURA2 trials and the next steps to identify who may benefit from which regimen.


  • White ribbons around CHEST HQ raise awareness for lung cancer screening and early detection

    White ribbons around CHEST HQ raise awareness for lung cancer screening and early detection

    During the month of November, CHEST displayed white ribbons around its headquarters in Glenview, Illinois, to raise awareness for lung cancer screening and early detection.


  • CHEST grant recipient studying increase in lung cancer diagnoses among Chinese American women

    CHEST grant recipient studying increase in lung cancer diagnoses among Chinese American women

    In his prior research, Chien-Ching Li, PhD, MPH, focused on promoting lung cancer screening in Chinese American men, a population that frequently smokes heavily. But last year, he applied for a CHEST grant that’s shifting his focus to another demographic: Chinese American women who do not smoke, especially those with limited English proficiency. “They are…


  • Biomarker checklist seeks to expedite NSCLC diagnoses

    Biomarker checklist seeks to expedite NSCLC diagnoses

    Establishing a systematic biomarker testing program for patients with suspected non-small cell lung cancer (NSCLC) takes both time and collaboration across specialties. To standardize this process, the American College of Chest Physicians (CHEST) created two clinician checklists for use in practice. The case-by-case checklist helps guide physicians to ensure timely and comprehensive biomarker testing for…